Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome.
Noblejas-López MDM, Nieto-Jiménez C, Morcillo García S, Pérez-Peña J, Nuncia-Cantarero M, Andrés-Pretel F, Galán-Moya EM, Amir E, Pandiella A, Győrffy B, Ocana A.
Noblejas-López MDM, et al. Among authors: nuncia cantarero m.
Oncoimmunology. 2019 Jul 3;8(10):e1629780. doi: 10.1080/2162402X.2019.1629780. eCollection 2019.
Oncoimmunology. 2019.
PMID: 31646075
Free PMC article.